Omalizumab Weight-Based Dosing Efficacy Trial

Clinical trial NCT06943534 · RECRUITING

Trial details

NCT number: NCT06943534
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allergies Food Allergy

Start date: 2025-07-03
Primary completion: 2027-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.